Published: August 2019
Owing to the benefits offered in terms of streamlining pharmaceutical filling operations and cutting down on associated costs, pre-sterilized container-closure systems have emerged as a promising alternative to conventional packaging components
Roots Analysis has announced the addition of “Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials, 2018-2030” report to its list of offerings.
Given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative to reevaluate drug / therapy packaging, taking into consideration the evident shift from large batches of one remedy for all patients suffering from a particular disease, to smaller batches of personalized therapeutics. Ready-to-use packaging components eliminate multiple steps in the overall fill / finish process, and thereby, help improve operational efficiencies in compliance to existing regulatory standards.
To order this 200+ page report, which features 70+ figures and 190+ tables, please visit this link
Over 70 pre-sterilized packaging products are currently available in the market
Close to 45% of these products represent vials, while nearly 30% are syringes. Further, over 45 players are engaged in providing packaging components, or equipment and services for processing ready-to-use products.
Stakeholders are actively collaborating with other players to strengthen their respective product portfolios
More than 50% of the partnership agreements in this domain were signed post 2016. In addition, over the past five years, acquisitions represented close to 40% of the deals related to ready-to-use packing products. Many players also entered into supply agreements and product development agreements in the given time period.
Packaging industry is gradually evolving to cater to the changing needs of drug manufacturers
Manufacturers are improving their offerings by focusing on enhancing safety. Further, certain packaging developers and equipment suppliers have collaborated to validate container-closure product sets of ready-to-use primary packaging. In addition, several other players are exploring the use of robotic technologies and automated equipment in order to further optimize pharmaceutical fill / finish processes.
North America and Europe are anticipated to capture over 60% of the market share by 2030
With the rising demand for flexible fill / finish solutions and various initiatives to automate such operations, the market is anticipated to grow at a healthy rate. In addition to the US and Europe, we expect Asia Pacific to grow at a relatively faster pace. Currently, revenues from the sale of ready-to-use vials represent about 60% of the overall market share. However, in the future, both vials and syringes are likely to hold the dominant share in this market.
To request a sample copy / brochure of this report, please visit this link
The USD 1.6 billion (by 2030) financial opportunity within the ready-to-use primary packaging market has been analyzed across the following segments:
The research covers profiles of key players that offer services for ready-to-use container closure systems, featuring an overview of the company, its financial information (if available), and a description of its product(s). Each company profile includes a section on recent developments (if available) and future outlook to highlight the strategies that the company may adopt to drive its future growth.
or email email@example.com
You may also be interested in the following titles:
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES